Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
184,457
clinical trials

Chronic Hepatitis B Clinical Trial
Tenofovir Alafenamide (TAF) in Children and Adolescents With Chronic Hepatitis B Virus Infection
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Chronic Hepatitis B Clinical Trial
Tenofovir Alafenamide (TAF) in Children and Adolescents With Chronic Hepatitis B Virus Infection
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
Chronic Hepatitis B Clinical Trial
Tenofovir Alafenamide (TAF) in Children and Adolescents With Chronic Hepatitis B Virus Infection
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Kansas City, MO
Click here to add this to my saved trials
Chronic Hepatitis B Clinical Trial
Tenofovir Alafenamide (TAF) in Children and Adolescents With Chronic Hepatitis B Virus Infection
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Kansas Hospital-Indian Creek Campus
mi
from
Overland Park, KS
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling, Phase III
Updated: 12/31/1969
South Florida Baptist Hospital
mi
from
Plant City, FL
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling, Phase III
Updated: 12/31/1969
Geisinger Cancer Services-Pottsville
mi
from
Pottsville, PA
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling, Phase III
Updated: 12/31/1969
Reid Health
mi
from
Richmond, IN
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling, Phase III
Updated: 12/31/1969
Oncology Hematology Associates of Saginaw Valley PC
mi
from
Saginaw, MI
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling, Phase III
Updated: 12/31/1969
Saint Joseph Heritage Healthcare-Santa Rosa
mi
from
Santa Rosa, CA
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling, Phase III
Updated: 12/31/1969
Fox Valley Hematology and Oncology SC - Shawano
mi
from
Shawano, WI
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling, Phase III
Updated: 12/31/1969
CHRISTUS Highland Medical Center
mi
from
Shreveport, LA
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling, Phase III
Updated: 12/31/1969
Saint Vincent Hospital Cancer Center at Sturgeon Bay
mi
from
Sturgeon Bay, WI
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology Clinical Trial
Ensartinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With ALK or ROS1 Genomic Alterations (A Pediatric MATCH Treatment Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
PI3K/mTOR Inhibitor LY3023414 in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With TSC or PI3K/MTOR Mutations (A Pediatric MATCH Treatment Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
Kaiser Permanente Downey Medical Center
mi
from
Downey, CA
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
PI3K/mTOR Inhibitor LY3023414 in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With TSC or PI3K/MTOR Mutations (A Pediatric MATCH Treatment Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
University of Florida Health Science Center ?? Gainesville
mi
from
Gainesville, FL
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
PI3K/mTOR Inhibitor LY3023414 in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With TSC or PI3K/MTOR Mutations (A Pediatric MATCH Treatment Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
Alliance for Childhood Diseases/Cure 4 the Kids Foundation
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology Clinical Trial
Selumetinib Sulfate in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Activating MAPK Pathway Mutations (A Pediatric MATCH Treatment Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
Norton Children's Hospital
mi
from
Louisville, KY
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Larotrectinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With NTRK Fusions (A Pediatric MATCH Treatment Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
Kaiser Permanente Downey Medical Center
mi
from
Downey, CA
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Larotrectinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With NTRK Fusions (A Pediatric MATCH Treatment Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
University of Florida Health Science Center ?? Gainesville
mi
from
Gainesville, FL
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Larotrectinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With NTRK Fusions (A Pediatric MATCH Treatment Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
Alliance for Childhood Diseases/Cure 4 the Kids Foundation
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Continued Access Protocol for the Evaluation of the OPTIMIZER Smart System
Status: Enrolling
Updated: 12/31/1969
Southwest Cardiology Associates
mi
from
Mesa, AZ
Click here to add this to my saved trials
Thyroid Cancer Clinical Trial
RAI Plus Immunotherapy for Recurrent/Metastatic Thyroid Cancers
Status: Enrolling, Phase
Updated: 12/31/1969
Memoral Sloan Kettering Monmouth
mi
from
Middletown, NJ
Click here to add this to my saved trials
Thyroid Cancer Clinical Trial
RAI Plus Immunotherapy for Recurrent/Metastatic Thyroid Cancers
Status: Enrolling, Phase
Updated: 12/31/1969
Memorial Sloan Kettering Rockville Centre
mi
from
Rockville Centre, NY
Click here to add this to my saved trials
Oncology Clinical Trial
Lung-MAP: Nivolumab With or Without Ipilimumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers
Status: Enrolling, Phase III
Updated: 12/31/1969
Saint Alphonsus Medical Center-Baker City
mi
from
Baker City, OR
Click here to add this to my saved trials
Oncology Clinical Trial
Lung-MAP: Nivolumab With or Without Ipilimumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers
Status: Enrolling, Phase III
Updated: 12/31/1969
Indu and Raj Soin Medical Center
mi
from
Beavercreek, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Lung-MAP: Nivolumab With or Without Ipilimumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers
Status: Enrolling, Phase III
Updated: 12/31/1969
Waldo County General Hospital
mi
from
Belfast, ME
Click here to add this to my saved trials
Oncology Clinical Trial
Lung-MAP: Nivolumab With or Without Ipilimumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers
Status: Enrolling, Phase III
Updated: 12/31/1969
MaineHealth/SMHC Cancer Care and Blood Disorders-Biddeford
mi
from
Biddeford, ME
Click here to add this to my saved trials
Oncology Clinical Trial
Lung-MAP: Nivolumab With or Without Ipilimumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers
Status: Enrolling, Phase III
Updated: 12/31/1969
IHA Hematology Oncology Consultants-Canton
mi
from
Canton, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Lung-MAP: Nivolumab With or Without Ipilimumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers
Status: Enrolling, Phase III
Updated: 12/31/1969
SIH Cancer Institute
mi
from
Carterville, IL
Click here to add this to my saved trials
Oncology Clinical Trial
Lung-MAP: Nivolumab With or Without Ipilimumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers
Status: Enrolling, Phase III
Updated: 12/31/1969
IHA Hematology Oncology Consultants-Chelsea
mi
from
Chelsea, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Lung-MAP: Nivolumab With or Without Ipilimumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers
Status: Enrolling, Phase III
Updated: 12/31/1969
UCHealth Memorial Hospital Central
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
Oncology Clinical Trial
Lung-MAP: Nivolumab With or Without Ipilimumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers
Status: Enrolling, Phase III
Updated: 12/31/1969
The Women's Imaging Center
mi
from
Denver, CO
Click here to add this to my saved trials
Oncology Clinical Trial
Lung-MAP: Nivolumab With or Without Ipilimumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers
Status: Enrolling, Phase III
Updated: 12/31/1969
Beaumont Hospital - Farmington Hills
mi
from
Farmington Hills, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Lung-MAP: Nivolumab With or Without Ipilimumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers
Status: Enrolling, Phase III
Updated: 12/31/1969
Great Lakes Cancer Management Specialists-Van Elslander Cancer Center
mi
from
Grosse Pointe Woods, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Lung-MAP: Nivolumab With or Without Ipilimumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers
Status: Enrolling, Phase III
Updated: 12/31/1969
Lymphoma Clinic of Michigan
mi
from
Grosse Pointe Woods, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Lung-MAP: Nivolumab With or Without Ipilimumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers
Status: Enrolling, Phase III
Updated: 12/31/1969
Comprehensive Cancer Centers of Nevada-Horizon Ridge
mi
from
Henderson, NV
Click here to add this to my saved trials
Oncology Clinical Trial
Lung-MAP: Nivolumab With or Without Ipilimumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers
Status: Enrolling, Phase III
Updated: 12/31/1969
Hawaii Oncology Inc-Kuakini
mi
from
Honolulu, HI
Click here to add this to my saved trials
Oncology Clinical Trial
Lung-MAP: Nivolumab With or Without Ipilimumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers
Status: Enrolling, Phase III
Updated: 12/31/1969
Oncology Center of The South Incorporated
mi
from
Houma, LA
Click here to add this to my saved trials
Oncology Clinical Trial
Lung-MAP: Nivolumab With or Without Ipilimumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers
Status: Enrolling, Phase III
Updated: 12/31/1969
Capital Region Southwest Campus
mi
from
Jefferson City, MO
Click here to add this to my saved trials
Oncology Clinical Trial
Lung-MAP: Nivolumab With or Without Ipilimumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers
Status: Enrolling, Phase III
Updated: 12/31/1969
OhioHealth Mansfield Hospital
mi
from
Mansfield, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Lung-MAP: Nivolumab With or Without Ipilimumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers
Status: Enrolling, Phase III
Updated: 12/31/1969
Saint Vincent Hospital Cancer Center at Marinette
mi
from
Marinette, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Lung-MAP: Nivolumab With or Without Ipilimumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers
Status: Enrolling, Phase III
Updated: 12/31/1969
Marshfield Medical Center
mi
from
Marshfield, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Lung-MAP: Nivolumab With or Without Ipilimumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers
Status: Enrolling, Phase III
Updated: 12/31/1969
City of Hope Mission Hills
mi
from
Mission Hills, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Lung-MAP: Nivolumab With or Without Ipilimumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers
Status: Enrolling, Phase III
Updated: 12/31/1969
Pacific Cancer Care-Monterey
mi
from
Monterey, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Lung-MAP: Nivolumab With or Without Ipilimumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers
Status: Enrolling, Phase III
Updated: 12/31/1969
UPMC-Coraopolis/Heritage Valley Radiation Oncology
mi
from
Moon, PA
Click here to add this to my saved trials
Oncology Clinical Trial
Lung-MAP: Nivolumab With or Without Ipilimumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers
Status: Enrolling, Phase III
Updated: 12/31/1969
Franciscan Health Mooresville
mi
from
Mooresville, IN
Click here to add this to my saved trials
Oncology Clinical Trial
Lung-MAP: Nivolumab With or Without Ipilimumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers
Status: Enrolling, Phase III
Updated: 12/31/1969
AMG Oncology - Naperville
mi
from
Naperville, IL
Click here to add this to my saved trials
Orthopedics / Podiatry Clinical Trial
Investigation of Rifampin to Reduce Pedal Amputations for Osteomyelitis in Diabetics
Status: Enrolling, Phase IV
Updated: 12/31/1969
Rocky Mountain Regional VA Medical Center, Aurora, CO
mi
from
Aurora, CO
Click here to add this to my saved trials
Abdominal Injury Clinical Trial
Contrast-Enhanced Ultrasound in the Evaluation of Abdominal Injuries in Children
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Children's Mercy Kansas City
mi
from
Kansas City, MO
Click here to add this to my saved trials
Clinical Trial
Trametinib in Treating Patients With Epithelioid Hemangioendothelioma That Is Metastatic, Locally Advanced, or Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
Nebraska Medicine-Village Pointe
mi
from
Omaha, NE
Click here to add this to my saved trials
Clinical Trial
Trametinib in Treating Patients With Epithelioid Hemangioendothelioma That Is Metastatic, Locally Advanced, or Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
Stanford Cancer Institute Palo Alto
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Coronary Artery Disease Clinical Trial
RESOLUTE ONYX Post-Approval Study
Status: Enrolling, Phase
Updated: 12/31/1969
University of Michigan Health System - University Hospital
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Coronary Artery Disease Clinical Trial
RESOLUTE ONYX Post-Approval Study
Status: Enrolling, Phase
Updated: 12/31/1969
Ziekenhuis Oost Limburg - Campus Sint-Jan
mi
from
Genk,
Click here to add this to my saved trials
Coronary Artery Disease Clinical Trial
RESOLUTE ONYX Post-Approval Study
Status: Enrolling, Phase
Updated: 12/31/1969
TriStar Centennial Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Coronary Artery Disease Clinical Trial
RESOLUTE ONYX Post-Approval Study
Status: Enrolling, Phase
Updated: 12/31/1969
Saint Francis Hospital (Roslyn NY)
mi
from
Roslyn, NY
Click here to add this to my saved trials
Migraine Clinical Trial
Status Migrainosus - Differentiating Between Responders and Non-responders
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Hartford HealthCare Headache Center
mi
from
Wethersfield, CT
Click here to add this to my saved trials
Small Bowel Crohn's Disease Clinical Trial
Efficacy and Safety of Filgotinib in the Treatment of Small Bowel Crohn's Disease (SBCD)
Status: Enrolling, Phase II
Updated: 12/31/1969
University of Miami Crohn's and Colitis Center
mi
from
Miami, FL
Click here to add this to my saved trials
Relapsing, Remitting Multiple Sclerosis Clinical Trial
Pilot Study to Assess the Efficacy & Safety of H.P. Acthar® Gel in Subjects With Relapsing-remitting Multiple Sclerosis
Status: Enrolling, Phase IV
Updated: 12/31/1969
NYU Langone Multiple Sclerosis Comprehensive Care Center
mi
from
New York, NY
Click here to add this to my saved trials
HIV INfections Clinical Trial
Connecting Youth and Young Adults to Optimize ART Adherence: YouTHrive Efficacy Trial
Status: Enrolling, Phase II
Updated: 12/31/1969
Montefiore Children's Hospital
mi
from
Bronx, NY
Click here to add this to my saved trials
HIV INfections Clinical Trial
Connecting Youth and Young Adults to Optimize ART Adherence: YouTHrive Efficacy Trial
Status: Enrolling, Phase II
Updated: 12/31/1969
Cook County Hospital and Health Systems CORE Center
mi
from
Chicago, IL
Click here to add this to my saved trials
PreTerm Birth Clinical Trial
Serum Assessment of Preterm Birth: Outcomes Compared to Historical Controls: AVERT PRETERM TRIAL
Status: Enrolling
Updated: 12/31/1969
Christaina Hospital
mi
from
Newark, DE
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
A Study of Melflufen-dex or Pomalidomide-dex for RRMM Patients Refractory to Lenalidomide
Status: Enrolling, Phase III
Updated: 12/31/1969
US13
mi
from
Boston, MA
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
A Study of Melflufen-dex or Pomalidomide-dex for RRMM Patients Refractory to Lenalidomide
Status: Enrolling, Phase III
Updated: 12/31/1969
US07
mi
from
Canton, OH
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
A Study of Melflufen-dex or Pomalidomide-dex for RRMM Patients Refractory to Lenalidomide
Status: Enrolling, Phase III
Updated: 12/31/1969
US06
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
A Study of Melflufen-dex or Pomalidomide-dex for RRMM Patients Refractory to Lenalidomide
Status: Enrolling, Phase III
Updated: 12/31/1969
US-19
mi
from
Plantation, FL
Click here to add this to my saved trials
Benign Centrally-Located Intracranial Tumors Clinical Trial
A Feasibility Safety Study of Benign Centrally-Located Intracranial Tumors in Pediatric and Young Adult Subjects
Status: Enrolling
Updated: 12/31/1969
Miami Children's Research Institute - Nicklaus Children's Hospital
mi
from
Miami, FL
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Saroglitazar Magnesium in Patients With Nonalcoholic Fatty Liver Disease and/or Nonalcoholic Steatohepatitis
Status: Enrolling, Phase II
Updated: 12/31/1969
Avail Clinical Research, LLC
mi
from
Orange City, FL
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Saroglitazar Magnesium in Patients With Nonalcoholic Fatty Liver Disease and/or Nonalcoholic Steatohepatitis
Status: Enrolling, Phase II
Updated: 12/31/1969
Wake Internal Medicine
mi
from
Raleigh, NC
Click here to add this to my saved trials
Heart Failure Clinical Trial
Strategic MAnagement to Optimize Response To Cardiac Resynchronization Therapy Registry
Status: Enrolling, Phase
Updated: 12/31/1969
Flinders Medical Centre
mi
from
Bedford Park,
Click here to add this to my saved trials
Heart Failure Clinical Trial
Strategic MAnagement to Optimize Response To Cardiac Resynchronization Therapy Registry
Status: Enrolling, Phase
Updated: 12/31/1969
Trinity Medical WNY, PC
mi
from
Buffalo, NY
Click here to add this to my saved trials
Heart Failure Clinical Trial
Strategic MAnagement to Optimize Response To Cardiac Resynchronization Therapy Registry
Status: Enrolling, Phase
Updated: 12/31/1969
Riverside Medical Center / Midwest Arrhythmia Consultants
mi
from
Kankakee, IL
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
Norton Children's Hospital
mi
from
Louisville, KY
Click here to add this to my saved trials
Significant Bleeding Risk Clinical Trial
Study of Octaplex, a Four-factor Prothrombin Complex Concentrate (4F-PCC) and Beriplex® P/N (Kcentra) for the Reversal of Vitamin K Antagonist (VKA) Induced Anticoagulation in Patients Needing Urgent Surgery With Significant Bleeding Risk.
Status: Enrolling, Phase III
Updated: 12/31/1969
Octapharma Research Site
mi
from
Denver, CO
Click here to add this to my saved trials
Significant Bleeding Risk Clinical Trial
Study of Octaplex, a Four-factor Prothrombin Complex Concentrate (4F-PCC) and Beriplex® P/N (Kcentra) for the Reversal of Vitamin K Antagonist (VKA) Induced Anticoagulation in Patients Needing Urgent Surgery With Significant Bleeding Risk.
Status: Enrolling, Phase III
Updated: 12/31/1969
Octapharma Research Site
mi
from
Puyallup, WA
Click here to add this to my saved trials
Congenital Heart Defect Clinical Trial
Exclusive Human Milk Feeding in Infants With Single Ventricle Physiology
Status: Enrolling
Updated: 12/31/1969
Cincinatti Children's Hospital Medical Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Culturally Tailored Decision Aid for Hispanic Patients Diagnosed With Prostate Cancer
Status: Enrolling
Updated: 12/31/1969
University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Hepatitis C Virus Infection Clinical Trial
Sofosbuvir/Velpatasvir in Adolescents and Children With Chronic HCV Infection
Status: Enrolling, Phase II
Updated: 12/31/1969
Johns Hopkins University (JHU) - The Johns Hopkins Hospital (JHH)
mi
from
Baltimore, MD
Click here to add this to my saved trials
Hepatitis C Virus Infection Clinical Trial
Sofosbuvir/Velpatasvir in Adolescents and Children With Chronic HCV Infection
Status: Enrolling, Phase II
Updated: 12/31/1969
Florida Gastroenterology Care for Children
mi
from
Orlando, FL
Click here to add this to my saved trials
Oncology Clinical Trial
Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of INCAGN01876 Combined With Immune Therapies in Advanced or Metastatic Malignancies
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Blacktown Cancer & Haematology Centre
mi
from
Blacktown,
Click here to add this to my saved trials
Oncology Clinical Trial
Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of INCAGN01876 Combined With Immune Therapies in Advanced or Metastatic Malignancies
Status: Enrolling, Phase I, II
Updated: 12/31/1969
University of Pittsburgh, UPMC Cancer Pavilion
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Mild Cognitive Impairment Clinical Trial
Memory Improvement Through Nicotine Dosing (MIND) Study
Status: Enrolling, Phase II
Updated: 12/31/1969
Perseverance Research Center
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Clostridium Difficile Infection Recurrence Clinical Trial
Efficacy, Safety, and Tolerability Study of Oral Full-Spectrum MicrobiotaTM (CP101) in Subjects With Recurrent C. Diff
Status: Enrolling, Phase II
Updated: 12/31/1969
Butte
mi
from
Butte, MT
Click here to add this to my saved trials
Clostridium Difficile Infection Recurrence Clinical Trial
Efficacy, Safety, and Tolerability Study of Oral Full-Spectrum MicrobiotaTM (CP101) in Subjects With Recurrent C. Diff
Status: Enrolling, Phase II
Updated: 12/31/1969
Hamden
mi
from
Hamden, CT
Click here to add this to my saved trials
Pediatric Crohn's Disease Clinical Trial
Low Dose Oral Methotrexate in Pediatric Crohn's Disease Patients Initiating Anti-Tumor Necrosis Factor (Anti-TNF) Therapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Pediatric Specialists Of Virginia
mi
from
Fairfax, VA
Click here to add this to my saved trials
Pediatric Crohn's Disease Clinical Trial
Low Dose Oral Methotrexate in Pediatric Crohn's Disease Patients Initiating Anti-Tumor Necrosis Factor (Anti-TNF) Therapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Upstate Golisano Children's Hospital
mi
from
Syracuse, NY
Click here to add this to my saved trials
Pediatric Crohn's Disease Clinical Trial
Low Dose Oral Methotrexate in Pediatric Crohn's Disease Patients Initiating Anti-Tumor Necrosis Factor (Anti-TNF) Therapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Nemours Children's Health System - Wilmington
mi
from
Wilmington, DE
Click here to add this to my saved trials
Adenoviral Conjunctivitis Clinical Trial
Treatment of Adenoviral Conjunctivitis With SHP640 Compared to Povidone-iodine (PVP-I) and Placebo
Status: Enrolling, Phase III
Updated: 12/31/1969
Shire Call Center
mi
from
Lexington, MA
Click here to add this to my saved trials
Adenoviral Conjunctivitis Clinical Trial
Treatment of Adenoviral Conjunctivitis With SHP640 Compared to Povidone-iodine (PVP-I) and Placebo
Status: Enrolling, Phase III
Updated: 12/31/1969
Eye Specialty Group
mi
from
Memphis, TN
Click here to add this to my saved trials
Adenoviral Conjunctivitis Clinical Trial
Treatment of Adenoviral Conjunctivitis With SHP640 Compared to Povidone-iodine (PVP-I) and Placebo
Status: Enrolling, Phase III
Updated: 12/31/1969
Nashville Vision Associates
mi
from
Nashville, TN
Click here to add this to my saved trials
Adenoviral Conjunctivitis Clinical Trial
Treatment of Adenoviral Conjunctivitis With SHP640 Compared to Povidone-iodine (PVP-I) and Placebo
Status: Enrolling, Phase III
Updated: 12/31/1969
Pediatric & Adult Research Center, LLC
mi
from
Orlando, FL
Click here to add this to my saved trials
Adenoviral Conjunctivitis Clinical Trial
Treatment of Adenoviral Conjunctivitis With SHP640 Compared to Povidone-iodine (PVP-I) and Placebo
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Trials Research
mi
from
Roseville, CA
Click here to add this to my saved trials
Adenoviral Conjunctivitis Clinical Trial
Treatment of Adenoviral Conjunctivitis With SHP640 Compared to Povidone-iodine (PVP-I) and Placebo
Status: Enrolling, Phase III
Updated: 12/31/1969
Lone Star Eye Care, P.A.
mi
from
Sugar Land, TX
Click here to add this to my saved trials
Gastroenterology Clinical Trial
ALPCO Calprotectin ELISA - Measurement of Calprotectin Levels in Human Stool
Status: Enrolling
Updated: 6/27/2017
ALPCO
mi
from
Salem, NH
Click here to add this to my saved trials
Blood Pressure Clinical Trial
Blood Pressure Checks for Diagnosing Hypertension (BP-CHECK)
Status: Enrolling
Updated: 10/24/2017
Kaiser Permanente Washington
mi
from
Seattle, WA
Click here to add this to my saved trials
Oral Sedation and Cervical Dilator Pain Clinical Trial
Oral Sedation During Cervical Dilator Placement
Status: Enrolling, Phase IV
Updated: 12/31/1969
Johns Hopkins' Women's Center for Family Planning
mi
from
Baltimore, MD
Click here to add this to my saved trials
Hemophilia A Clinical Trial
Non-interventional Post-authorisation Study to Document the Immunogenicity, Safety, and Efficacy of NUWIQ
Status: Enrolling, Phase
Updated: 12/31/1969
Gulf States Hemophilia and Thrombophilia
mi
from
Houston, TX
Click here to add this to my saved trials
Myelodysplastic Syndromes (MDS) Clinical Trial
A Study Evaluating Venetoclax Alone and in Combination With Azacitidine in Subjects With Relapsed/Refractory Myelodysplastic Syndromes (MDS)
Status: Enrolling, Phase I
Updated: 12/31/1969
The University of Chicago /ID# 155364
mi
from
Chicago, IL
Click here to add this to my saved trials
Critical Limb Ischemia (CLI) Clinical Trial
Efficacy, Tolerability and Safety of Intramuscular Injections of PLX PAD for the Treatment of Subjects With Critical Limb Ischemia (CLI) With Minor Tissue Loss Who Are Unsuitable for Revascularization
Status: Enrolling, Phase III
Updated: 12/31/1969
Austin Heart Clinical Research
mi
from
Austin, TX
Click here to add this to my saved trials
Critical Limb Ischemia (CLI) Clinical Trial
Efficacy, Tolerability and Safety of Intramuscular Injections of PLX PAD for the Treatment of Subjects With Critical Limb Ischemia (CLI) With Minor Tissue Loss Who Are Unsuitable for Revascularization
Status: Enrolling, Phase III
Updated: 12/31/1969
Tufts Medical Center (TMC) (Tufts-New England Medical Center)
mi
from
Boston, MA
Click here to add this to my saved trials